Petros Efthimiou, MD
NPI 1942246939ActiveIndividual· Internal Medicine, Rheumatology· New York, NY
Opted out of Medicare from January 2025 to January 2027. Internal Medicine, Rheumatology (MD) in New York, New York, licensed in NY, with an NPI issued in June 2006. Their prescriptions cost Medicare Part D more than their services did: $1,676,533 for 571 claims, against $47,522 paid for services in 2024. Genzyme Corporation was the largest of 11 companies reporting payments in 2025, $38,420 in all, mostly speaking and faculty fees.
Overview
| NPI | 1942246939 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jun 20, 2006 |
| Last updated in NPPES | Mar 12, 2025 |
| Certified by provider | Mar 12, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | 268774 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jan 27, 2025 – Jan 27, 2027 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 113 |
|---|---|
| Services billed | 987 across 18 procedure codes |
| Paid by Medicare | $47,522 |
Part D prescriptions in 2024
| Prescriptions (claims) | 571 · 1,075 30-day fills |
|---|---|
| Patients | 101 |
| Total drug cost | $1,676,533 |
| Generic share | 78% of claims |
Industry payments (Open Payments)
- 2025$38,420 · 58 payments from 11 companies
- 2024$95,927 · 168 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Genzyme Corporation | $17,431 | 11 |
| Ani Pharmaceuticals, Inc. | $7,827 | 7 |
| Amgen Inc. | $7,800 | 14 |
| Mallinckrodt Hospital Products Inc. | $1,183 | 2 |
| Aurinia Pharma U.S., Inc. | $1,181 | 3 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$25,736 · 9 payments
- Honoraria$7,613 · 4 payments
- Food and Beverage$2,425 · 35 payments
- Consulting Fee$1,653 · 2 payments
- Travel and Lodging$914.62 · 7 payments
- Education$79.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Rheumatology providers in New York
- 1013839174
- 1437162088
- 1457436552
- 1902105869
- 1356664122
- 1992946776
- 1932388170
- 1043571086
- 1881598209
- 1780988717
- 1184816340
- 1982992251